Supporting global efforts to end AIDS by 2032 through the introduction of lenacapavir as a game-changing HIV prevention tool ...

The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future AIDS deaths and new infections, while being a cost-effective alternative to oral PrEP, ...

Stakeholders emphasized that the Needle Syringe Program has been proven effective in other parts of the world, and with Fiji ...

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

HIV has been a disease of younger adults, but the need for long-term care is increasing as more patients surpass their 50th birthdays and develop comorbidties much more common in older people.

With AIDS Walk L.A. days away, Phill Wilson reflects on decades of HIV/AIDS research and prevention and looks ahead as those ...

Following a Supreme Court of Appeal ruling, the Pimart initiative will enhance access to HIV and Aids treatment in South ...

Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. A free zoom seminar this Friday, July 24, 2020 from 12:00-2:00pm PT. This ...

The Ghana AIDS Commission has announced plans to introduce an HIV preventive vaccine by 2026 as part of efforts to reduce new infections and strengthen the country’s fight against the virus.

It is estimated that 180 million people worldwide and 5 million people in the US are infected with hepatitis C virus (HCV). 1 In the US, most individuals infected with HCV have not been diagnosed. The ...

Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment Before the introduction of highly active antiretroviral therapy ...